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Abstract
Four million people die each year from diseases caused byBackground: 
exposure to household air pollution. There is an association between exposure
to household air pollution and pneumonia in children (half a million attributable
deaths a year); however, whether this is true in adults is unknown. We
conducted a case-control study in urban Malawi to examine the association
between exposure to household air pollution and pneumonia in adults.
Hospitalized patients with radiologically confirmed pneumoniaMethods: 
(cases) and healthy community controls underwent 48 hours of ambulatory and
household particulate matter (µg/m ) and carbon monoxide (ppm) exposure
monitoring. Multivariate logistic regression, stratified by HIV status, explored
associations between these and other potential risk factors with pneumonia.
145 (117 HIV-positive; 28 HIV-negative) cases and 253 (169Results: 
HIV-positive; 84 HIV-negative) controls completed follow up. We found no
evidence of association between household air pollution exposure and
pneumonia in HIV-positive (e.g. ambulatory particulate matter adjusted odds
ratio [aOR] 1.00 [95% CI 1.00–1.01, p=0.141]) or HIV-negative (e.g. ambulatory
particulate matter aOR 1.00 [95% CI 0.99–1.01, p=0.872]) participants. Chronic
respiratory disease was associated with pneumonia in both HIV-positive (aOR
28.07 [95% CI 9.29–84.83, p<0.001]) and HIV-negative (aOR 104.27 [95% CI
12.86–852.35, p<0.001]) participants.
We found no evidence that exposure to household air pollutionConclusions: 
is associated with pneumonia in Malawian adults. In contrast, chronic
respiratory disease was strongly associated with pneumonia.
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Introduction
Four million people die each year from diseases caused by expo-
sure to household air pollution from the domestic burning of solid 
fuels1. Half a million of these deaths are due to acute lower respira-
tory infections (ALRI) in young children2. In adults, the majority of 
deaths are attributed to chronic obstructive lung disease, cardiovas-
cular diseases, and lung cancer3. Although plausible, it is not known 
if household air pollution is associated with ALRI in adults as it is 
in children4.
In low-income areas such as Malawi, pneumonia is the common-
est cause of admission to hospital for adults and has a high fatality 
rate5–7. HIV infection is a well-established risk factor for 
pneumonia; the extent to which other factors, such as household 
air pollution and other poverty-related exposures, affect the risk 
of pneumonia has not been adequately studied4,8. In low-income 
countries burdened with high rates of adult pneumonia, domestic 
use of solid fuel is widespread1. If an association between house-
hold air pollution and adult ALRI is found, the attributable risk is 
potentially high.
We conducted a case-control study, The Acute Infection of the 
Respiratory tract (AIR) study, to test the hypothesis that house-
hold air pollution and chronic respiratory disease (CRD) are 
associated with an increased risk of pneumonia in adults living in 
urban Malawi.
Methods
Setting
Malawi, population 16.7 million, is one of the world’s poorest 
countries, and has a life expectancy of 59 years9,10. Blantyre, 
Malawi’s second city, has a HIV prevalence of 18.5%11. Queen 
Elizabeth Central Hospital (QECH) is a large government 
hospital providing free health care to a population of 1.3 million in 
greater Blantyre.
Participants
Cases were defined by the presence of radiologically-confirmed 
pneumonia requiring hospitalisation and controls were defined 
by the absence of pneumonia. Inclusion and exclusion criteria are 
presented in Box 1.
All adult medical admissions to QECH were screened for 
symptoms suggestive of pneumonia by study clinical officers to 
identify potential cases. For control recruitment, residential census 
enumeration areas were randomly selected from all enumeration 
areas within Blantyre city, with selection weighted by population 
size. Field workers followed randomly generated routes within 
these enumeration areas and screened all potential participants 
(including performing HIV tests) in each household along the 
route. A maximum of one individual was recruited per household, 
selected randomly. Screening continued until two controls had 
been recruited from that enumeration area. To supplement 
Box 1. Inclusion and exclusion criteria for cases and controls.
CASES CONTROLS
 
In
cl
us
io
n 
cr
ite
ria
Age 18 years or over 
Resident in Blantyre city 
Reported cough or chest pain or breathlessness or 
hemoptysis 
Reported fever or recorded fever (≥38°C) 
Crepitations or pleural rub or bronchial breathing 
Radiological changes judged to be new and consistent 
with pneumonia, without another obvious cause 
Requires hospitalisation
Age 18 years or over 
Resident in Blantyre city
Ex
cl
us
io
n 
cr
ite
ria
 
Pre–admission diagnosis of terminal illness  
(e.g., metastatic malignancy, terminal AIDS) 
Current anti–tuberculosis treatment or evidence of 
current tuberculosis infection 
Prior hospitalisation within the last 4 weeks 
Prior participation in the study 
Lives in a residential institution (e.g., prison) 
Death prior to follow–up assessment 
Alternative diagnosis explaining their presentation 
Symptoms for 14 days or more
Pre–admission diagnosis of terminal illness 
(e.g., metastatic malignancy, terminal AIDS) 
Current anti–tuberculosis treatment or evidence of 
current tuberculosis infection 
Hospitalisation for a pneumonia–like illness in the 
past 4 months or current pneumonia–like illness 
Prior participation in the study 
Lives in a residential institution (e.g., prison) 
Death prior to follow–up assessment 
Utilizes private health care facilities if has illness 
requiring hospitalisation
Note 
For pragmatic reasons relating to resource availability, individuals could be recruited as a ‘provisional case’ prior to having a 
chest x-ray. Individuals were subsequently excluded if there was no evidence of pneumonia on chest x-ray or if they later met 
exclusion criteria (e.g. were commenced on tuberculosis treatment or died). Individuals were designated as a ‘case’ only when 
they had completed follow-up.
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door–to–door recruitment, HIV–positive individuals attending 
community antiretroviral clinics within Blantyre city were also 
screened. Recruitment was stratified by HIV status to enable the 
data to be analyzed as two separate case–control studies. Within 
these two subgroups, controls were frequency–matched to cases 
by age (18–34 years or ≥35 years) and gender.
Cases and controls were contemporaneously recruited and fol-
lowed-up throughout the study period, to account for temporal 
changes in air pollution exposure related to season. Case recruitment 
was from July 2014 until January 2016, and follow up appointments 
took place between September 2014 and March 2016. Control 
recruitment and follow up appointments took place from August 
2014 until February 2016.
Study procedures
Initial assessment of provisional cases included medical history 
and examination by study clinical officers, and diagnostic tests 
(Box 2). Pneumonia was confirmed by chest X-ray review by a 
study clinical officer and a study doctor.
Box 2. Hospital diagnostic tests for provisional cases.
•   HIV test +/- CD4 count
•   Malaria rapid diagnostic test
•   Blood culture
•   BinaxNOW® Streptococcus pneumoniae urinary antigen
•    Sputum for acid-fast bacilli smear, mycobacterial culture, and 
GeneXpert® MTB/RIF
•    Pleural fluid specimen for acid-fast bacilli smear and 
mycobacterial culture (if clinically indicated)
•   Chest X-ray
Follow-up assessments were conducted in the participants’ homes. 
Continuous ambulatory and household monitoring of particulate 
matter <2.5 µm diameter (PM2.5, µg/m3) and carbon monoxide parts 
per million (CO, ppm) was performed for 48 hours. Participants 
wore backpacks with Aprovecho Indoor Air Pollution meters, 
while UCB-PATS (Particle and Temperature Sensor, University 
of California, Berkeley) and Lascar EL-USB-CO Data Logger 
monitors were placed 1 meter (m) from the household’s cooking 
stove or fire at an elevation of 1 m. Spirometry was conducted 
using an EasyOne Spirometer (ndd Medical Technologies, 
Zurich, Switzerland) to American Thoracic Society standards12. 
NHANES III reference ranges, corrected for Caucasian ethnic-
ity, were used to calculate predicted values. Two reviewers (HJ, 
and Lindsay Zurba (Spirometry Training Services Africa CC)) 
independently performed quality assurance and spirometry inter-
pretation. Questionnaires (see Supplementary File 1), including 
items from the Burden of Obstructive Lung Disease (BOLD) 
questionnaires13, evaluated a range of potential risk factors and 
socioeconomic status. The primary exposures of interest were mean 
ambulatory PM2.5 exposure and presence of CRD (defined using 
a composite questionnaire assessment (Box 3)). The full study 
protocol has been published elsewhere14.
Box 3. Composite definition of chronic respiratory disease
Answering affirmative to any of the following in the BOLD 
questionnaire:
•   Current usual cough
•   Current usual sputum production
•   Current breathlessness
•   Wheeze in past 12 months
•   Ever had diagnosis of emphysema
•   Current diagnosis of chronic bronchitis
•   Current diagnosis of asthma
•   Current long-term respiratory medication
Note: Cases were asked to recall their status from 6 months 
previously, prior to their episode of pneumonia.
Sample size
Based on assumptions of α=0.05, β=0.2, and an estimated per-
centage of controls with CRD of at least 15%, the target sample 
size was 160 cases and 160 controls in the HIV-positive subgroup 
(ratio 1:1) to detect an odds ratio (OR) of 2.2 or greater. A smaller 
exploratory study was planned with 60 cases and 90 controls in 
the HIV-negative subgroup (ratio 1:1.5).
Statistical considerations
Data files were exported to Stata 13.1 (Statacorp, College Station, 
TX, USA) for analysis. Missing air pollution exposure data (for 
ambulatory PM2.5 and CO levels and household CO levels) were 
imputed using spatial interpolation. Due to the large number of 
missing data, household PM2.5 data were not imputed. Missing 
questionnaire data were imputed using multivariate multinomial 
models by exploiting their association with other observed vari-
ables. A socioeconomic status score was generated using princi-
pal components analysis, based on data regarding asset-based 
measures, education level, and household characteristics15.
Univariate logistic regression, including a priori potential con-
founders, was performed for each subgroup. For analysis of the 
HIV-positive subgroup, multivariate forward stepwise logis-
tic regression was performed for each of the main exposures of 
interest (a priori potential confounders (as indicated in Table 2 
and Supplementary File 2) were included in the model if their 
likelihood ratio test p-value was <0.2 (criteria for entry p<0.05 
and removal p>0.1)). Adjustment in the HIV-negative subgroup 
was limited to frequency-matched factors (age and sex).
To test the hypothesis that pneumonia cases are spatially clustered, 
we used generalized additive models and smoothing latitude and 
longitude over the geographic reach of the study area16.
Ethical considerations
This study was approved by the College of Medicine Research 
Ethics Committee, University of Malawi (P.02/14/1518) and the 
Liverpool School of Tropical Medicine Research Ethics Committee 
(14.016). All participants gave written informed consent prior to 
participation in the study.
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Results
Participant recruitment
We screened 2148 and 1492 potential cases and controls, respec-
tively, between July 2014 and February 2016. Of the screened 
cases, 58.5% were men with a median age of 36 years (interquartile 
range (IQR) 30–47). Of the screened controls, 61.6% were men, 
with a median age of 30 (IQR 23–40). From HIV-positive and 
HIV-negative groups, respectively, we recruited 349 and 79 provi-
sional cases, and 208 and 92 controls (Figure 1). Of the recruited 
participants, 64.7% and 59.3% were male, with a median age of 
35 (IQR 30–42, range 18–89) and 35 (IQR 29–43, range 18–78) 
in the provisional cases and controls, respectively, and lived 
across Blantyre city (Figure 2). The main reasons for ineligibility 
amongst potential screened cases were symptom duration greater 
than 14 days (913, 42.5%), lack of clinical signs consistent with 
pneumonia (416, 19.4%), living outside of urban Blantyre (385, 
17.9%) and absence of fever (304, 14.2%). The main reasons 
for ineligibility amongst potential controls were not meeting 
HIV status/sex/age requirements for stratified recruitment (682, 
45.7%), current evidence of tuberculosis or tuberculosis treatment 
(55, 3.7%), and recent pneumonia-like illness (45, 3.0%). One 
hundred and forty-five (117 HIV-positive, 28 HIV-negative) 
cases and 253 (169 HIV-positive, 84 HIV-negative) controls com-
pleted follow-up. Reasons for not completing follow-up amongst 
recruited provisional cases were subsequent exclusion for ineli-
gibility (264, 61.7%; including lack of radiological evidence of 
pneumonia (93, 21.7%), commencement of tuberculosis treat-
ment (114, 26.6%), and death (64, 15.0%)), and loss to follow-up 
(19, 4.4%) (Figure 1). Among recruited controls, 34 individuals 
(11.3%) were lost to follow-up and 13 (4.3%) were ineligible and 
subsequently excluded.
Baseline characteristics of cases
Comparisons between cases who completed follow-up and 
provisional cases who did not complete follow-up (predominantly 
due to ineligibility, see Figure 1) were made to explore evidence of 
Figure 1. Participant flow chart showing the number of cases and controls screened, recruited, and followed up in the HIV–positive 
and HIV–negative subgroups.
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Figure 2. Participant household locations. A map of Blantyre city, 
Southern Region, Malawi showing the location of case (•) and control 
(•) households. Mapping software: Google Earth Pro (7.1.5.1157).
ambulatory and household PM2.5 and CO had no effect on pneu-
monia risk with unadjusted ORs of approximately one for all 
measures of exposure (Table 2). In the HIV-positive subgroup, 
there were no consistent findings related to frequency of cook-
ing with solid fuels and no significant findings relating to fuel 
use, household ventilation, or other forms of pollution expo-
sure (Table 2 and Supplementary File 2). In the HIV-negative 
subgroup, cooking with wood (OR 13.33 [95% CI 1.32–134.61, 
p=0.028]) and cooking inside without ventilation (OR 12.25 [95% 
CI 1.79–83.95, p=0.011]) were both associated with an increased 
risk of pneumonia.
CRD was associated with an increased risk of pneumonia in both 
study groups (HIV-positive: OR 20.58 [95% CI 8.58–49.38], 
p<0.001; and HIV-negative: OR 106.41 [95% CI 13.49–839.66, 
p<0.001]). Factors associated with a reduced risk were taking 
antiretroviral treatment (OR 0.42 [95% CI 0.25–0.70, p=0.001]), 
increasing BMI (HIV-positive: OR 0.85 [95% CI 0.78–0.92, 
p<0.001]; HIV-negative: 0.84 [95% CI 0.72–0.98, p=0.023]) 
and increasing CD4 count (cells/µl) (OR 0.99 [95% CI 0.99–
0.99, p<0.001]) (Table 2). In the HIV-positive group, socioeco-
nomic status was not associated with pneumonia (OR 1.01 [95% 
CI 0.85–1.20, p=0.943]), but there was an increased risk of 
pneumonia with decreasing socioeconomic status in the HIV- 
negative group (OR 1.38 [95% CI 1.02–1.85, p=0.034]). Further 
potential risk factors and confounding factors are reported in 
Supplementary File 2.
Spirometry
Two independent reviewers deemed the spirometry data usable 
as per American Thoracic Society standards in 349 (87.7%) par-
ticipants who completed follow-up. The two reviewers agreed on 
the spirometry interpretation for 99.1% of participants. Of the 91 
(72.8%) cases that had abnormal spirometry at their initial follow-up 
appointment, it was only possible to repeat spirometry in 13 
(14.3%) a minimum of 4 months after their pneumonia episode 
to determine their final spirometry status: spirometry remained 
abnormal in all these individuals. Pre-bronchodilator percent-
age of predicted forced expiratory volume in 1 second and forced 
vital capacity were lower in cases than in controls in both the 
HIV-positive and HIV-negative subgroups (Table 2). Restric-
tive spirometry was a risk factor for pneumonia in the HIV- 
positive subgroup only (OR 2.87 [95% 1.61–5.07, p<0.001]), 
whereas obstructive spirometry was predictive of pneumonia 
in both subgroups (HIV-positive: OR 2.71 [95% CI 1.22–6.04, 
p=0.014]; and HIV-negative: OR 4.93 [95% CI 1.39-17.54, 
p=0.014]). Abnormal spirometry was associated with the pres-
ence of CRD (composite definition) in the HIV-positive subgroup 
(Pearson’s chi-square test, p<0.001), but not in the HIV-negative 
group (p=0.165).
Multivariate analysis of potential risk factors
After adjustment for confounders, mean ambulatory and house-
hold PM2.5 and CO exposures were not associated with pneumo-
nia in the HIV-positive or HIV-negative subgroups (Table 3). CRD 
had a substantial effect on pneumonia risk in both HIV- 
positive and HIV-negative subgroups (OR 28.07 [95% CI 9.28–
84.83 p<0.001] and OR 104.27 [95% CI 12.86–852.35, p<0.001], 
potential selection bias (Table 1). Those who completed follow-up 
had a higher admission CD4 count than those who were not fol-
lowed up (median 119 cells/µl (IQR 47–205) vs. median 86 cells/µl 
(IQR 30–185)).
Overall, 349 provisional cases (81.5%) were HIV-positive, with 33 
(9.5%) of those newly diagnosed. One hundred and eighty-eight 
(78.0%) of those previously known to be HIV-positive were tak-
ing antiretroviral treatment prior to admission. One hundred and 
twenty-four (85.5%) provisional cases reported a previous diagno-
sis of emphysema and 34 (23.4%) reported previous tuberculosis. 
Forty-six (10.7%) provisional cases died prior to hospital discharge 
and a further 18 (5.2%) died following discharge, prior to follow-
up. Note that post-discharge mortality was only known for those 
who had not already been excluded.
Air pollution monitoring
Ambulatory PM2.5 exposure data was available for 379 (95.2%) 
of participants who completed follow-up, while ambulatory CO, 
household PM2.5, and household CO exposure data were available 
for 388 (97.5%), 258 (64.8%), and 375 (94.2%) of participants, 
respectively (Table 2). Data were missing because of technical 
faults with the pollution monitoring devices. Median duration 
between recruitment and monitoring was 11 days (IQR 6–24) 
and 65 days (IQR 57–83) for ambulatory exposures, and 11 days 
(IQR 6–23) and 64 days (IQR 57–78) for household exposures, for 
controls and cases respectively. There was no significant difference 
in month of exposure monitoring between cases and controls (data 
not shown).
Univariate analysis of potential risk factors
Findings were consistent for pollution assessment modalities 
in both HIV-positive and HIV-negative subgroups: exposure to 
Page 6 of 14
Wellcome Open Research 2017, 2:103 Last updated: 28 NOV 2017
Table 1. Baseline hospital data for all recruited cases. Baseline clinical data for cases who 
completed follow up and provisional cases who did not complete follow up.
Cases who completed 
follow-up (total n=145)
Provisional cases 
who did not complete 
follow-up (total n=283)
Symptom duration* (days), median (IQR) 7 (5–8) 7 (5–10)
Length of admission* (days), median (IQR) 5 (4–8) 7 (4–12)
Hospital outcome, n (%) 
Alive 
Dead 
Unknown
 
145 (100.0) 
0 (0) 
0 (0)
 
232 (82.0) 
46 (16.3) 
5 (1.8)
Pre-hospital antibiotics, n (%) 
Yes 
No 
Unknown
 
79 (54.5) 
59 (40.7) 
7 (4.8)
 
158 (55.8) 
111 (39.2) 
14 (4.9)
Systolic blood pressure* (mmHg), mean (STD) 104.4 (22.5) 112.1 (79.5)
Diastolic blood pressure* (mmHg), mean (STD) 67.0 (14.5) 75.5 (81.1)
Heart rate* (bpm), mean (STD) 116.5 (20.0) 116.5 (22.6)
Respiratory rate* (bpm), median (IQR) 28 (23–36) 28 (24–34)
Oxygen saturation* (%), median (IQR) 95 (91–97) 95 (90–98)
Temperature (°C), median (IQR) 38.2 (37.1–39.0) 37.8 (36.7–38.7)
HIV-positive, n (%) 117 (80.7) 232 (82.0)
Diagnosis of HIV†, n (%) 
Previously known 
New diagnosis 
Unknown
 
76 (64.9) 
17 (14.5) 
24 (20.5)
 
165 (71.1) 
16 (6.9) 
51 (22.0)
CD4†* (cells/µl), median (IQR) 119 (47-205) 86 (30-185)
Pre-hospital antiretroviral treatment‡, n (%) 60 (79.0) 128 (77.6)
Pre-hospital cotrimoxazole prophylaxis‡, n (%) 59 (77.6) 120 (72.7)
Chest X-ray changes consistent with 
pneumonia*, n (%)
145 (100) 190 (73.4)
Confirmed diagnosis of tuberculosis*, n (%) 0 (0) 67 (33.2)
In-hospital commencement of tuberculosis 
treatment*, n (%)
0 (0) 91 (33.0)
Positive malaria rapid diagnostic test*, n (%) 4 (3.0) 5 (1.9)
Positive blood culture*, n (%) 7 (5.3) 20 (7.5)
Positive BinaxNOW Streptococcus pneumoniae 
urinary antigen*, n (%) 34 (25.2) 48 (19.1)
*Missing data was not imputed; †of those who are human immunodeficiency virus-positive; ‡of those who were 
previously known to be HIV-positive.
STD: standard deviation; bpm: beats/breaths per minute; IQR: interquartile range.
respectively). Factors associated with a reduced risk of pneumo-
nia after adjustment for confounders in the HIV-positive subgroup 
included body mass index (BMI; HIV-positive: OR 0.85 [95% CI 
0.75–0.95, p=0.008]), increasing CD4 count (OR 0.99 [95% CI 
0.99–0.99, p<0.001]) and antiretroviral therapy (OR 0.23 [95% 
CI 0.09–0.60, p=0.002]). In the HIV-negative subgroup, after 
adjustment for age and sex, being an ex-smoker (OR 5.92 [95% 
CI 1.69–20.79, p=0.006]) and cooking inside without ventilation 
(OR 9.32 [95% CI 1.24–69.81, p=0.030]) were associated with an 
increased risk of pneumonia and increasing BMI (OR 0.84 [95% CI 
0.72–0.99, p=0.036]) was found to be protective. We did not find 
evidence of spatial clustering in pneumonia risk, with all p-values 
for the test on the presence of residual spatial effects being well 
above 10%.
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Table 3. Multivariate analysis of the effects of household air pollution 
exposure and chronic respiratory disease on pneumonia risk in HIV-
positive and HIV-negative sub-groups.
Exposures Adjusted OR  (95% CI) p-value
HIV-positive subgroup
Mean ambulatory PM2.5 exposure (µg/m
3)* 1.00 (1.00–1.01) 0.141
Mean ambulatory CO exposure (ppm)* 1.07 (1.00–1.14) 0.052
Mean household PM2.5 exposure (µg/m
3)†§ 1.00 (1.00–1.00) 0.608
Mean household CO exposure (ppm)* 1.03 (1.00–1.07) 0.081
Chronic respiratory disease* 28.07 (9.29–84.83) < 0.001 
HIV-negative subgroup
Mean ambulatory PM2.5 exposure (µg/m
3)‡ 1.00 (0.99–1.01) 0.872
Mean ambulatory CO exposure (ppm)‡ 0.95 (0.87–1.03) 0.219
Mean household PM2.5 exposure (µg/m
3)‡§ 1.00 (1.00–1.00) 0.307
Mean household CO exposure (ppm)‡ 0.96 (0.91–1.02) 0.206
Chronic respiratory disease‡ 104.27 (12.86–852.35) <0.001 
*Adjusted for age, sex, CD4, chronic respiratory disease, antiretroviral treatment, body 
mass index, occupational status and alcohol intake; †adjusted for age, sex, CD4, chronic 
respiratory disease and antiretroviral treatment; ‡adjusted for age and sex. §Missing 
household PM2.5 data were not imputed; therefore, analyses were restricted to 169 and 79 
observations in the HIV–positive and HIV–negative subgroups, respectively.
OR: odds ratio; CI: confidence interval; PM2.5: particulate matter <2.5µm; CO: carbon 
monoxide; ppm: parts per million.
Discussion
We found no association between household air pollution 
exposure, measured using ambulatory and household monitor-
ing of pollutants, and radiologically confirmed pneumonia in 
urban HIV-positive Malawian adults. This was consistent when 
measuring ambulatory and household PM2.5 and CO, and self-
reported exposures. Similar results were found in an exploratory 
study of HIV-negative individuals. In contrast, we found a strong 
association between CRD (defined by participant-reported symp-
toms and diagnoses), as well as spirometric abnormalities, and 
pneumonia in both HIV-positive and HIV-negative individuals in 
this setting.
The AIR study and our earlier BOLD study in Malawi both 
found a high prevalence of restrictive lung disease17. The under-
lying etiology, pathology, epidemiology and prognosis of this low 
FVC phenomenon requires further investigation, particularly 
since low FVC is associated with increased mortality in other 
settings18,19. The relationship identified by AIR between restric-
tion and pneumonia is potentially relevant to our understanding 
of this increased mortality.
It seems likely that socioeconomic factors explain the unex-
pected findings of reduced risk of pneumonia in current smokers 
and consumers of alcohol, as in the context of urban Malawi, the 
poorest individuals cannot afford cigarettes and alcohol20. The low 
prevalence of smoking in this setting means that smoking is not a 
major driver of pneumonia risk in multivariate analysis, unlike in 
higher resourced countries21.
Reduced BMI was a strong predictor for pneumonia in both 
subgroups, even after adjustment for CD4 in the HIV-positive 
subgroup; malnutrition may play a role in pneumonia risk, as has 
been shown in children22. Further research into nutritional status 
in this population and possible interventions is warranted.
This is the only study of household air pollution and pneumo-
nia in adults to have used multiple measurements of air pollution 
exposure with radiologically confirmed hospitalised pneumonia 
cases. While there is no gold standard method for air pollution 
monitoring, measuring ambulatory and household levels of two 
different major components of air pollution (PM2.5 and CO) is likely 
to capture a representative picture of an individual’s total expo-
sure. Mean household PM2.5 levels detected (all homes: median 
149.5 µg/m3, IQR 85.0–289.0 µg/m3) and mean household CO 
levels (all homes: median 6.4 ppm, IQR 2.9–12.6ppm) were com-
parable to those detected in a previous study of urban Malawian 
homes (mean 150 µg/m3, standard deviation 360 µg/m3 and mean 
6.14 ppm, respectively)23. The detected levels of exposure greatly 
exceed the levels considered safe: WHO Air Quality Guidelines 
recommend not exceeding 24hour-mean PM2.5 levels of 25 µg/m324. 
Mean ambulatory PM2.5 levels detected (all participants: median 
59.4 µg/m3, IQR 39.6–96.1 µg/m3) equate to a 2.5%–5% increased 
risk of short-term mortality according to these guidelines.
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The latest Global Burden of Disease Study (2013) estimates for 
the burden of adult ALRI caused by household air pollution are 
based on data extrapolated from evidence for tobacco smoke and 
outdoor air pollution3. A systematic review found only a small 
number of studies, of limited quality, assessing the effects of 
household air pollution on ALRI in adults, and was thus unable to 
conclude that an effect exists4. Our findings are inconsistent with 
evidence presented by Ezzati and Kammen, who demonstrated 
a dose-dependent relationship between household air pollution 
exposure and ALRI25. This study from rural Kenya conducted 
household monitoring prospectively for 12 hours per day over a 
2-year period, but did not use radiologically confirmed pneumo-
nia, did not account for HIV status, and their cohort included 
children over the age of 5 years.
The lack of association between household air pollution and 
ALRI in adults identified in this study may be explained by the 
overwhelming effect of other major risk factors (such as CRD, 
HIV-associated factors and BMI) in this setting. This could 
explain why an association is evident in children but not adults, 
in whom lifelong exposure to other factors plays a more important 
role2. Alternatively, it is possible that we have not detected a true 
association between household air pollution and ALRI in adults 
owing to methodological limitations, in particular with exposure 
assessments.
Although the AIR study is the largest and most detailed study of 
household air pollution and ALRI in adults to date, it has a number 
of limitations. We were unable to evaluate HIV-positive and HIV-
negative individuals together due to a lack of statistical power, 
but our findings were broadly consistent across both groups. The 
original sample size for both groups was not met because recruit-
ment was slower than anticipated leading to lower power to detect 
an effect. However, in the HIV-positive group, we were able to 
detect an OR greater than 1.0003 per unit change for ambulatory 
PM2.5 exposure (our primary exposure of interest) with 80% power. 
Findings in the HIV-negative group are exploratory only. Potential 
risk factors were assessed after the episode of pneumonia, and so 
questionnaire assessments may have been subject to recall bias. 
Our composite assessment of CRD is not validated and may have 
been vulnerable to recall bias, although our findings are corrobo-
rated by spirometric data. Objective measurements of air pollu-
tion exposures were made, but these may not be representative of 
pre-pneumonia exposures, although 138/142 (97.2%) cases reported 
that they had returned to normal levels of function. A sensitivity 
analysis, in which cases without reported full functional recovery 
were excluded, also found no effects of mean ambulatory PM2.5 
exposure (data not shown). In addition, our exposure monitoring 
does not account for differences in exposure over the life course. 
The ambulatory pollutant monitoring is unable to distinguish 
between outdoor and indoor exposures, although since our findings 
are consistent across ambulatory, household, and questionnaire 
assessments, we argue that our findings are reflective of the effects 
of household air pollution.
Pneumonia is a major health burden in sub-Saharan Africa3. 
Although there are compelling reasons for tackling household 
air pollution26, other issues need to be addressed to reduce the 
burden of pneumonia in adults. Evidence from this study can be 
used to establish global estimates for the contribution of house-
hold air pollution exposure to the burden of disease, to ensure the 
limited available resources for public health interventions are 
appropriately directed. Risk factors associated with pneumonia 
in this study, such as HIV and BMI, are typically associated with 
socioeconomic status, indicating that poverty is an important 
driver of pneumonia in urban African adults. To reduce the bur-
den of pneumonia, further research into the effects of CRD and the 
underlying etiologies in this setting are required. Prenatal and 
childhood malnutrition may play a role. Targeted evidence-
based strategies to reduce the high burden of CRD seen in young 
adults are needed and may help to tackle the high morbidity and 
mortality caused by pneumonia.
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